hotspot -WSS

hotspot

author：fashion 2025-09-30 20:34:34 - browse：8748

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： New company forms to vet health AI models, root out weaknesses

WSS

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Parkland mass shooting to be reenacted for lawsuit

STAT Summit: Ending the crisis of Black deaths in the U.S.

Results on Novartis prostate cancer therapy could expand its use

CZI to create biohub to build anti

Wikipedia

hotspot

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Study on Amgen’s bispecific immunotherapy produces positive data

Wildfire smoke exposes gaps in outdoor worker protections

Medical mystery: When an infection after surgery isn’t what it seems

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CZI to create biohub to build anti

The cancer drug shortage isn’t new — and neither are the solutions

Cassava Sciences’ Alzheimer’s clinical trials should be halted

What does generative AI mean for health care? We asked experts

STAT Summit: Ending the crisis of Black deaths in the U.S.

hotspot

STAT Readout: Friday, Oct. 20 biotech updates

Prosecutors seek bail revocation for FTX founder Sam Bankman

Medical schools are missing the mark on artificial intelligence

ADCs take center stage as promising cancer treatments

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Smaller biotechs seek to piggyback on weight loss drug boom

leisure time

hotspot

knowledge

focus